These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 10995245

  • 1. HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts.
    Cohen SM, Mikata Y, He Q, Lippard SJ.
    Biochemistry; 2000 Sep 26; 39(38):11771-6. PubMed ID: 10995245
    [Abstract] [Full Text] [Related]

  • 2. DNA sequence context and protein composition modulate HMG-domain protein recognition of cisplatin-modified DNA.
    Dunham SU, Lippard SJ.
    Biochemistry; 1997 Sep 23; 36(38):11428-36. PubMed ID: 9298962
    [Abstract] [Full Text] [Related]

  • 3. A single HMG domain in high-mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct.
    Chow CS, Barnes CM, Lippard SJ.
    Biochemistry; 1995 Mar 07; 34(9):2956-64. PubMed ID: 7893709
    [Abstract] [Full Text] [Related]

  • 4. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
    Ohndorf UM, Rould MA, He Q, Pabo CO, Lippard SJ.
    Nature; 1999 Jun 17; 399(6737):708-12. PubMed ID: 10385126
    [Abstract] [Full Text] [Related]

  • 5. RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II).
    Corda Y, Anin MF, Leng M, Job D.
    Biochemistry; 1992 Feb 25; 31(7):1904-8. PubMed ID: 1536834
    [Abstract] [Full Text] [Related]

  • 6. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
    Trimmer EE, Zamble DB, Lippard SJ, Essigmann JM.
    Biochemistry; 1998 Jan 06; 37(1):352-62. PubMed ID: 9425057
    [Abstract] [Full Text] [Related]

  • 7. Intercalating residues determine the mode of HMG1 domains A and B binding to cisplatin-modified DNA.
    He Q, Ohndorf UM, Lippard SJ.
    Biochemistry; 2000 Nov 28; 39(47):14426-35. PubMed ID: 11087395
    [Abstract] [Full Text] [Related]

  • 8. Laser-induced photo-cross-linking of cisplatin-modified DNA to HMG-domain proteins.
    Mikata Y, He Q, Lippard SJ.
    Biochemistry; 2001 Jun 26; 40(25):7533-41. PubMed ID: 11412107
    [Abstract] [Full Text] [Related]

  • 9. Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins.
    Kane SA, Lippard SJ.
    Biochemistry; 1996 Feb 20; 35(7):2180-8. PubMed ID: 8652559
    [Abstract] [Full Text] [Related]

  • 10. DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link on the conformational and thermodynamic properties of duplex DNA.
    Pilch DS, Dunham SU, Jamieson ER, Lippard SJ, Breslauer KJ.
    J Mol Biol; 2000 Feb 25; 296(3):803-12. PubMed ID: 10677282
    [Abstract] [Full Text] [Related]

  • 11. Repair of cisplatin--DNA adducts by the mammalian excision nuclease.
    Zamble DB, Mu D, Reardon JT, Sancar A, Lippard SJ.
    Biochemistry; 1996 Aug 06; 35(31):10004-13. PubMed ID: 8756462
    [Abstract] [Full Text] [Related]

  • 12. Stopped-flow fluorescence studies of HMG-domain protein binding to cisplatin-modified DNA.
    Jamieson ER, Lippard SJ.
    Biochemistry; 2000 Jul 25; 39(29):8426-38. PubMed ID: 10913248
    [Abstract] [Full Text] [Related]

  • 13. A rare example of three abundant conformers in one retro model of the cisplatin-DNA d(GpG) intrastrand cross link. Unambiguous evidence that guanine O6 to carrier amine ligand hydrogen bonding is not important. possible effect of the Lippard base pair step adjacent to the lesion on carrier ligand hydrogen bonding in DNA adducts.
    Sullivan ST, Ciccarese A, Fanizzi FP, Marzilli LG.
    J Am Chem Soc; 2001 Sep 26; 123(38):9345-55. PubMed ID: 11562217
    [Abstract] [Full Text] [Related]

  • 14. Interaction between cisplatin-modified DNA and the HMG boxes of HMG 1: DNase I footprinting and circular dichroism.
    Locker D, Decoville M, Maurizot JC, Bianchi ME, Leng M.
    J Mol Biol; 1995 Feb 17; 246(2):243-7. PubMed ID: 7869375
    [Abstract] [Full Text] [Related]

  • 15. Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts.
    Ohndorf UM, Whitehead JP, Raju NL, Lippard SJ.
    Biochemistry; 1997 Dec 02; 36(48):14807-15. PubMed ID: 9398202
    [Abstract] [Full Text] [Related]

  • 16. Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex.
    Hofr C, Farrell N, Brabec V.
    Nucleic Acids Res; 2001 May 15; 29(10):2034-40. PubMed ID: 11353072
    [Abstract] [Full Text] [Related]

  • 17. Two mutations of basic residues within the N-terminus of HMG-1 B domain with different effects on DNA supercoiling and binding to bent DNA.
    Stros M.
    Biochemistry; 2001 Apr 17; 40(15):4769-79. PubMed ID: 11294645
    [Abstract] [Full Text] [Related]

  • 18. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.
    Kaspárková J, Brabec V.
    Biochemistry; 1995 Sep 26; 34(38):12379-87. PubMed ID: 7547982
    [Abstract] [Full Text] [Related]

  • 19. LEF-1 recognition of platinated GG sequences within double-stranded DNA. Influence of flanking bases.
    Chválová K, Sari MA, Bombard S, Kozelka J.
    J Inorg Biochem; 2008 Feb 26; 102(2):242-50. PubMed ID: 17961652
    [Abstract] [Full Text] [Related]

  • 20. NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin.
    Gelasco A, Lippard SJ.
    Biochemistry; 1998 Jun 30; 37(26):9230-9. PubMed ID: 9649303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.